CURI vs NXST

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 15, 2026

CURI

33.8
AI Score
VS
NXST Wins

NXST

52.7
AI Score

Investment Advisor Scores

CURI

34score
Recommendation
SELL

NXST

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CURI NXST Winner
Revenue 38.41M 3.39B NXST
Net Income 7.55M 284.00M NXST
Net Margin 19.7% 8.4% CURI
Operating Income 7.64M 627.00M NXST
ROE 18.2% 12.5% CURI
ROA 11.2% 1.6% CURI
Total Assets 67.47M 17.71B NXST
Cash 5.38M 218.00M NXST
Current Ratio 0.78 1.56 NXST

Relative Price Performance (Last 90 Days)

CURI 1M: +20.9% · 3M: +11.4% NXST 1M: +1.6% · 3M: -1.3%

Current Technical Phase

CURI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.7 · Price: $2.84

NXST

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.7 · Price: $186.24

Fundamentals Snapshot

Metric CURI NXST
Market Cap
Forward P/E 9.2 8.0
Trailing P/E 35.3
Revenue (TTM)
Revenue Growth 0.2% 0.6%
Gross Margin 0.6% 0.6%
Operating Margin 0.4% 0.2%
EPS -0.01 5.28
Dividend Yield 0.11% 0.04%

Frequently Asked Questions

Based on our detailed analysis, NXST is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.